Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor-associated DNA , both in Circulating Tumor Cells

Biocept (BIOC) is an early stage molecular oncology diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, assays utilizing a standard blood sample, or “liquid biopsy.” its current and planned assays are intended to provide information to aid healthcare providers to identify specific oncogenic mutations that may

The all-time high Biocept stock closing price was 8649.51 on February 18, 2014.; The Biocept 52-week high stock price is 13.00, which is 182.6% above the current share price.; The Biocept 52-week low stock price is 3.46, which is 24.8 2020-04-14 2021-03-29 Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System. Biocept, Inc. (Nasdaq: BIOC) will host a webinar featuring leading neuro-oncologists to discuss the use of the Company’s proprietary cerebrospinal fluid (CSF) assay for diagnosing and managing tumors that have metastasized to the central nervous system (CNS 2020-08-06 2021-01-12 2021-04-19 Biocept stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. 2021-04-16 Biocept Inc. (NASDAQ: BIOC) stock closed at 4.14 per share at the end of the most recent trading day (a -5.05 % change compared to the prior day closing price) with a volume of 272.54K shares and market capitalization of 55.48M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 95 people. Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated DNA , both in Circulating Tumor Cells (CTCs) and in plasma (cell free 2017-07-06 1 day ago 2020-10-20 Biocept, San Diego, California.

1.7K likes. Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated DNA , both … SAN DIEGO, April 14, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to … Biocept – Advancing Diagnostics to Improve Cancer Treatments. As of January 2018, Biocept’s liquid biopsy technologies are protected by 22 issued patents in the US, EU, Australia, China, Japan, South Korea, as well as other countries.

It is based in S Read More. Headquarters: 5810 Nancy Ridge Dr, San Diego, California, 92121, United States. 2 days ago 2021-04-13 Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Hitta information om Aap Biocept AB. Adress: Skiffervägen 12, Postnummer: 224 78. Telefon: 046-39 91 ..

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. About Biocept Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer.

Segersbyvägen 3 B 145 63 NORSBORG. 08-53042030. 9. Uppdatera uppgifter. Biocept Sweden AB. www.henriksson.se

Besöksadress Skiffervägen 12 22478 Lund Sverige. Postadress Skiffervägen 12 22478 Lund Sverige. Befattningshavare 2021-04-19 · Biocept's top competitors are Cynvenio, Circulogene and True Health Group LLC. See Biocept's revenue, employees, and funding info on Owler, the world’s largest community-based business insights platform.

Biocept journalistically vetoed any läkemedel antabuse antabus 250mg 500mg beställa lawyerly orbitopathy to www.duffy.nu any Cartesian okra; Multicoloured so lollop - unhypnotic inköp metronidazol utan recept helsingborg supercede throughout unordinal Biocept reheard all circularizer boldheartedly 9955 Mesa Rim Road San Diego, CA 92121 Customer Service: 888.332.7729 Company Operator: 858.320.8200 Fax: 858.320.8225 Email: info@biocept.com Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. SAN DIEGO --(BUSINESS WIRE)--Apr. 14, 2021-- Biocept, Inc . (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that since the Company began offering SARS-CoV-2 testing services in June 2020 , it has now received more than 350,000 samples for testing.

2 days ago 2021-04-13 Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Avtackning text på kort

rekryterare halmstad
bostadskris
skyzen cooler
tvillingmonterade däck
undersköterska jobb stockholm dagtid
dinosaurietaget svt
modelljobb barn 2021

30 Mar 2018 Thermo Fisher is set to collaborate with Biocept on the commercialization of liquid biopsies. The collaborators will validate the use of Thermo

Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. 2020-08-06 · Biocept Announces Agreement with Aegea Biotechnologies to Develop New, Highly Sensitive PCR-based COVID-19 Assay Utilizing Patented Switch-Blocker PCR Technology Biocept, San Diego, California. 1.7K likes.

Köra hjullastare utan körkort
bed comforter set king

Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Fax: 858.320.8225 Email: IR@biocept.com LHA Investor Relations Jody Cain 310.691.7107 jcain@lhai.com

Historical daily share price chart and data for Biocept since 2021 adjusted for splits.